Takeda Pharmaceutical (TAK) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | 108.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.51% |
| Dec 31, 2025 | -0.61% |
| Sep 30, 2025 | 49.84% |
| Jun 30, 2025 | -50.55% |
| Mar 31, 2025 | -14,188.53% |
| Dec 31, 2024 | 29.59% |
| Sep 30, 2024 | -52.20% |
| Jun 30, 2024 | 1.52% |
| Mar 31, 2024 | 99.17% |
| Dec 31, 2023 | -207.75% |
| Sep 30, 2023 | -122.77% |
| Jun 30, 2023 | -4.28% |
| Mar 31, 2023 | -483.83% |
| Dec 31, 2022 | 26.10% |
| Sep 30, 2022 | 20.95% |
| Jun 30, 2022 | 22.41% |
| Mar 31, 2022 | 124.71% |
| Dec 31, 2021 | -9.19% |
| Sep 30, 2021 | -224.71% |
| Jun 30, 2021 | 2.06% |